Related by context. Frequent words. (Click for all words.) 65 HERmark 65 Carfilzomib 65 refractory chronic lymphocytic 64 AlloMap 63 proteasome inhibitor 63 K RAS 63 Epratuzumab 63 Zolinza 63 FAMILION 62 Factor VIIa 62 Dapagliflozin 62 DAVANAT 62 Metastatic Melanoma 62 CCX# 62 Amrubicin 62 Clinical Trial Results 62 liposomal formulation 62 Azedra 62 PreGen Plus 61 Traficet EN 61 sunitinib malate 61 Aliskiren 61 Dasatinib 61 Pivotal Phase III 61 rEEG 61 pharmacogenetic 61 rNAPc2 61 anticancer compound 61 gastrointestinal stromal tumors GIST 61 Phase III Clinical Trial 61 YERVOY 61 MVA BN R 61 predictive biomarkers 61 Sym# 61 HBsAg 61 enzastaurin 61 PEG SN# 61 PCA3 60 Pulmonary Arterial Hypertension 60 molecular biomarkers 60 Nanobody 60 Lenalidomide 60 Gemzar ® 60 Vitro Diagnostic 60 Thiarabine 60 Daclizumab 60 MammaPrint 60 Combination Therapy 60 Nexavar ® 60 Drug Candidate 60 Phase Ib II 60 ganetespib 60 Hexvix 60 Atopic Dermatitis 60 pertuzumab 60 Benign Prostatic Hyperplasia 60 NMP# 60 Gastric Cancer 60 elotuzumab 60 thymalfasin 60 BAY #-# 60 Gefitinib 60 Cancer Vaccines 60 Bavituximab 60 Thrombin 59 Golimumab 59 SNALP 59 Bevacizumab 59 FLT3 59 RGB # 59 MORAb 59 Recombinant Human 59 trastuzumab Herceptin 59 TLR9 agonist 59 Microplasmin 59 Hemopurifier 59 DDP# 59 Monoclonal Antibody 59 TELCYTA 59 Onko Sure ® 59 CD# antibody [001] 59 TH# [003] 59 phase IIb clinical 59 rilonacept 59 Initiate Phase 59 non squamous 59 Copegus R 59 renin inhibitors 59 Prognostic 59 Chronix 59 Erlotinib 59 tanespimycin 59 KNS # 59 pharmacokinetics PK 59 Privigen 59 Microvolt T Wave Alternans 59 Vilazodone 59 hypoxia inducible factor 59 molecular assays 59 PARP inhibitor 58 Oncotype DX breast cancer